Product No | EMEA/H/C/006019 |
---|---|
Brand Name | COVID-19 Vaccine (inactivated, adjuvanted) Valneva |
Nonproprietary Name | COVID-19 vaccine (inactivated, adjuvanted, adsorbed) |
API | SARS-CoV-2 virus (inactivated) Wuhan strain hCoV-19 / Italy / INMI1-isl / 2020 |
ATC Code | J07BX03 |
Indications | COVID-19 Vaccine (inactivated, adjuvanted) Valneva is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 18 to 50 years of age. The use of this vaccine should be in accordance with official recommendations. |
Orphan Drug | no |
Generics | no |
Marketing Authorization Holder | Valneva Austria GmbH |
Status | Authorised(授权) |
Authorization Date | 2022-06-24 |
Version | 6 |
Condition Approval | no |
Exceptions | no |
Biosimilar | no |
Details | 查看 (公众评估报告、授权细节、产品规格/剂型、标签、历史评估信息) |
Extended Information